This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Regents of the University of Minnesota. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: The Innovative Contributions of Jianming Wu
Introduction
Jianming Wu, based in Plymouth, MN, is an accomplished inventor with a remarkable portfolio of four patents. His work primarily focuses on advancements in biomedical applications, particularly relating to canine immunology. Wu's inventions have the potential to revolutionize therapeutic approaches and imaging techniques in veterinary medicine.
Latest Patents
Wu’s latest patents showcase his expertise in developing anti-canine polypeptides. His notable inventions include anti-canine CD16 polypeptides and anti-canine CD64 polypeptides. These polypeptides generally comprise specific CDR regions, such as SEQ ID NO:5 and SEQ ID NO:9 for the CD16 variant, and SEQ ID NO:13 and SEQ ID NO:17 for the CD64 variant. Furthermore, both polypeptides are designed to be incorporated into various compound formats, including therapeutic compounds, multispecific compounds, targeted imaging compounds, and capture assay devices. Additionally, Wu has worked on modified forms of CD16, which involve genetically engineered cells exhibiting enhanced anti-tumor and anti-viral activity due to their resistance to ADAM17-mediated shedding.
Career Highlights
Mr. Wu is currently affiliated with the University of Minnesota, where he applies his scientific knowledge and creativity to drive innovations in his field. Over the years, he has made significant strides in understanding canine immune responses and has contributed substantial findings that may benefit veterinary practices and animal health.
Collaborations
Jianming Wu has collaborated with fellow researchers such as Bruce Kenneth Walcheck and Dan Samuel Kaufman. These partnerships reflect a spirit of teamwork and shared knowledge, leading to advancements in immunology and therapeutic development.
Conclusion
Overall, Jianming Wu stands out as an influential figure in the realm of veterinary immunology. His extensive patent portfolio indicates his commitment to the innovation landscape, particularly in enhancing animal health through scientific discovery and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile